Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma.

Lavanya LokhandeVenera Kuci EmruliChristian Winther EskelundArne KolstadMartin HutchingsRiikka RätyCarsten Utoft NiemannKirsten GrønbaekMats JerkemanSara Ek

Published in: Cancer reports (Hoboken, N.J.) (2021)

We show that the genetic sub-type of MCL affects the biological response to treatment in serum and that the change in defined serum proteins reveals the biology associated with clinical response.

Keyphrases

acute lymphoblastic leukemia
combination therapy
dna methylation
genome wide
replacement therapy
multiple myeloma
hodgkin lymphoma